Skip to main content
Premium Trial:

Request an Annual Quote

GTC Wins Biogen Contract, Hits Schering Milestone

Premium

WALTHAM, Mass.--Genome Therapeutics has begun work on a sequencing contract for Biogen. Genome Therapeutics will employ its proprietary sequencing techniques, automation, bioinformatics, and quality control procedures to generate desired sequence reads and provide analysis of sequenced regions for Biogen.

Separately, the company announced that it has reached another milestone in its genomics research alliance with Schering-Plough by delivering assays for multiple targets related to two medically important fungal pathogens, Candida albicans and Aspergillus fumigatus. The milestone triggered a payment to Genome Therapeutics.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.